Amanda Liberman

Ms. Liberman spent her fellowship year at the Global Health Research Center of Central Asia in Kazakhstan at under the mentorship of Frederick Altice, MD, Sergii Dvoriak, MD, PhD and Assel Terlikbayeva, MD, MS. Her project focused on assessing barriers and facilitators to methadone in Kazakhstan using nominal group technique (NGT) to conduct anonymous focus groups with PWID and methadone providers (e.g. doctors, harmreduction workers, and directors of methadone clinics) and a legal landscape analysis of government documents that determine addiction treatment for the country.

Ms. Liberman is a medical student at Yale University. Her research interests are in infectious diseases, mixed methods, and mathematical modeling. She recently worked at the Center for Interdisciplinary Research on AIDS (CIRA) at Yale on projects that have involved mathematically modeling the number of deaths that could be prevented by upscaling various opioid use disorder (OUD) and HIV interventions, analyzing interview data about methadone use in prisons in the Kyrgyz Republic, and analyzing the results of a Screening, Brief Intervention, and Referral to Treatment pilot program conducted among people soon to be released from Kyrgyz prisons.